95 related articles for article (PubMed ID: 10025881)
1. Prognostic significance of soluble interleukin-2 receptor-alpha in adenocarcinoma of the pancreas.
Gansauge F; Steinbach G; Gansauge S; König HH; Müller J; Grünert A; Beger HG
Cancer Lett; 1998 Dec; 134(2):193-9. PubMed ID: 10025881
[TBL] [Abstract][Full Text] [Related]
2. Neopterin serum levels in pancreatic adenocarcinoma.
Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors.
Yoshida S; Morii K
J Surg Oncol; 2000 Oct; 75(2):131-5. PubMed ID: 11064393
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
[TBL] [Abstract][Full Text] [Related]
6. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer?
Kayhan B; Kayhan B; Akdoğan M
Int J Biol Markers; 2004; 19(3):196-202. PubMed ID: 15503821
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M
Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
[TBL] [Abstract][Full Text] [Related]
8. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
Jobin N; Garrel D; Bernier J
Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke.
Zhao H; Li F; Huang Y; Zhang S; Li L; Yang Z; Wang R; Tao Z; Han Z; Fan J; Zheng Y; Ma Q; Luo Y
J Neuroinflammation; 2020 Aug; 17(1):237. PubMed ID: 32795376
[TBL] [Abstract][Full Text] [Related]
11. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis.
Makis AC; Galanakis E; Hatzimichael EC; Papadopoulou ZL; Siamopoulou A; Bourantas KL
J Infect; 2005 Oct; 51(3):206-10. PubMed ID: 16230217
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer.
Tartour E; Mosseri V; Jouffroy T; Deneux L; Jaulerry C; Brunin F; Fridman WH; Rodriguez J
Lancet; 2001 Apr; 357(9264):1263-4. PubMed ID: 11418153
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era.
Procházka V; Papajík T; Faber E; Raida L; Kapitáňová Z; Langová K; Prouzová Z; Jarošová M; Indrák K
Leuk Lymphoma; 2014 Jul; 55(7):1584-90. PubMed ID: 24180329
[TBL] [Abstract][Full Text] [Related]
17. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
Rabitti PG; Pacelli L; Uomo G; Laccetti M; Spada OA; Esposito G; Visconti M
Minerva Gastroenterol Dietol; 1994 Sep; 40(3):101-3. PubMed ID: 7948318
[TBL] [Abstract][Full Text] [Related]
19. Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis.
Birk D; Gansauge F; Gansauge S; Schwarz A; Beger HG
Eur J Med Res; 1999 Apr; 4(4):156-60. PubMed ID: 10205291
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
